BOSTON -- The debut of DNA testing at your local drug store has been put on hold. Walgreens has halted the sale of the new, at-home genetic kit, after the Food and Drug Administration raised concerns.

As NewsCenter 5's Heather Unruh reported Thursday, the test claims to help determine your risk for diseases like Alzheimer's and breast cancer.

Amid the toothpaste and deodorant aisle, the drugstore chain Walgreens had plans to start selling a new kit to test your DNA. It claims to determine your risk for diseases like breast cancer, Alzheimer's, even your reaction to certain drugs.

The kit, made by Pathway Genomics, planned to start distributing the saliva swab test on Friday. It costs around $20. Then consumers have to pay almost $249 to get a complete DNA report for dozens of genetic conditions, including diabetes and Alzheimer's, along with the risk for heart attack, lung cancer and multiple sclerosis.

"And with that information you make better lifestyle choices," said Jim Woodman of Pathway Genomics, the company that makes the kit.

"Having the genetic marker doesn't mean anyone has the disease, or will develop the disease," said Dr. Michael Grodin, a professor of Health Law, Bioethics, and Human Rights at Boston University School of Public Health.

Not only do critics warn the results could be misleading to consumers, but the government is also raising concerns. The FDA says the kit has not been approved. Because of the FDAs concerns, Walgreens confirmed that will not sell the product, for now.

"It's not a good idea at all. Mostly what they're going to find out that it's not going to be helpful. And what they do find out to help them when in fact it doesn't," Grodin said.